Contract Manufacturing Resource Center
Manufacturing HP active pharmaceutical ingredient drugs is a challenge best met with a thorough assessment of risk and a robust containment strategy
Collaboration in the supply chain will help Pharma stay out in front of the challenges ahead
Gaining both mass and velocity, Biopharma is an industry on the move
Pharmaceutical manufacturing capacity is increasingly global and going biologic, but challenged to meet the realities of cGMP
White Papers: In Depth Research
Posted: Nov 21, 2014
If you are a pharmaceutical company seeking guidance for outsourcing your contract manufacturing, then there are a number of considerations that factor into the decision of where, and how, you will begin the process.
Posted: Oct 28, 2014
While highly potent compounds can have significant benefits in the treatment of certain medical conditions, they present substantial challenges to the pharmaceutical industry.
Posted: Oct 14, 2014
The manufacture of a Highly Potent Active Pharmaceutical Ingredient (HPAPI) compound can present many challenges due to the complex handling required for toxic substances.
Posted: Sep 22, 2014
Metrics are an objective measure of the quality of a product or process, the quality of a site and the effectiveness of systems associated with the manufacture of products, including the pharmaceutical quality systems.